[Mechanism of the ulcerogenic effects of phenylbutazone and indomethacin].
D000315:Adrenalectomy / Q000009:adverse effects; D000818:Animals; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects; D006168:Guinea Pigs; D006640:Histidine Decarboxylase / Q000378:metabolism; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D051379:Mice; D010437:Peptic Ulcer / Q000139:chemically induced*; D010653:Phenylbutazone / Q000008:administration & dosage / Q000009:adverse effects*; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced; D014628:Vagotomy / Q000009:adverse effects
D006640:Histidine Decarboxylase; D010653:Phenylbutazone; D007213:Indomethacin
K mechanismu ulcerogénneho úcinku fenylbutazónu a indometacínu.